Dag Nyholm graduated as MD in 1999 and defended his PhD thesis 'Pharmacotherapy for Parkinson's disease - observations and innovations' at Uppsala University Hospital, Sweden, in 2003. Development of intestinal infusion of levodopa has been the major focus of research. He currently combines clinical work at the neurology clinic with research in movement disorders.
FAIR PARK II
Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone
People
Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon pauline.guyon@chru-lille.fr
Senior Project Manager (IT): Delphine Smagghe delphine.smagghe@inserm-transfert.fr
Project Manager (IT): Stephanie Le Naour stephanie.lenaour@inserm-transfert.fr
Addresses
Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633190.
© FAIRPARK II 2015